AbbVie (ABBV)

Undervalued Growth and Dividend Growth in Health Technology: Part 11

2019-03-19

Research Articles

Introduction Although many Health Technology Sector companies have significantly outperformed the market on a long-term basis, they have significantly underperformed the market since the beginning of 2015.  With only a few minor exceptions, this is true for most companies, especially the pharmaceutical companies, operating in this sector. On the other hand, there are several examples […]

Building a Dividend Growth Portfolio from Scratch: 15 A Rated or Better Fairly Valued Opportunities

2018-10-17

Research Articles

Introduction We remain in one of the longest bull markets in history.  Generally, with bull markets stocks tend to become highly valued.  Additionally, we also continue to find ourselves in a low interest rate environment based on historical standards.  However, after bottoming out in January 2017, interest rates have steadily increased.  Although interest rates remain […]

Disclaimers: F.A.S.T. Graphs, Inc. is not a broker-dealer or a registered investment adviser. Under no circumstances does any information on Fastgraphs.com constitute a recommendation to buy or sell a security, nor does it give investment advice. This is to include any publications or articles on Fastgraphs.com. Fastgraphs.com is a research tool to be used by its subscribers in conjunction with the subscribers’ additional research and due diligence. The information on this site is in no way guaranteed for completeness or accuracy.